71372-37-7

Basic information

• Product Name: (4-HYDROXYPHENYL)(M-TOLYL)METHANONE
• Synonyms: (4-HYDROXYPHENYL)(M-TOLYL)METHANONE
• CAS NO: 71372-37-7
• Molecular Formula: C₁₄H₁₂O₂
• Molecular Weight: 212.24
• Mol File: 71372-37-7.mol
• Article Data: 3

Chemical Properties

• Melting Point: 166°C
• Appearance: /
• CAS DataBase Reference: (4-HYDROXYPHENYL)(M-TOLYL)METHANONE(CAS DataBase Reference)
• NIST Chemistry Reference: (4-HYDROXYPHENYL)(M-TOLYL)METHANONE(71372-37-7)
• EPA Substance Registry System: (4-HYDROXYPHENYL)(M-TOLYL)METHANONE(71372-37-7)

Safety Data

• Hazardous Substances Data: 71372-37-7(Hazardous Substances Data)

Usage

Preparation

Preparation by Fries rearrangement of phenyl m-toluate in the presence of aluminium chloride in refluxing carbon disulfide for 2 h, then elimination of the solvent and heating at 150° for 3 h (major product).

Upstream product

• 53039-63-7 (4-methoxyphenyl)(3-methylphenyl)methanone 
• 100-66-3 methoxybenzene 
• 108-95-2 phenol 
• 99-04-7 m-Toluic acid 

Relevant articles and documents

PHOTOACTIVATABLE FOULING-RESISTANT COPOLYMERS

A photoactivatable fouling-resistant copolymer composed of a photoactivatable monomer and a hydrophilic monomer is disclosed. The photoactivatable monomer includes an aryl ketone derivative having one or more polar groups or alkyl groups.

Quinoline and quinazoline derivatives inhibiting platelet-derived growth factor receptor autophosphorylation and pharmaceutical compositions containing the same

The present invention relates to novel quinoline derivatives and quinazoline derivatives represented by the following formula (I): STR1 [wherein R 1 and R 2 are each independently H or C 1 -C 4 -alkyl, or R 1 and R 2 together form C 1 -C 3 -alkylene, X is O, S or CH 2, W is CH or N, and Q is a substituted aryl group or substituted heteroaryl group] and their pharmaceutically acceptable salts, having platelet-derived growth factor receptor autophosphorylation inhibitory activity, to pharmaceutical compositions containing these compounds, and to methods for the treatment of diseases associated with abnormal cell growth such as tumors.